Full Text
PAR4 ETANERCEPT VERSUS INFLIXIMAB PLUS METHOTREXATE IN RHEUMATOID ARTHRITIS- A COST-EFFECTIVENESS ANALYSIS FROM THE ITALIAN NHS PERSPECTIVE

Abstract

Authors

S Lopatriello P Berto

Back to Volume 6, Issue 6
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×